Atlas Trials

Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study

Clinical trial NCT05782972 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05782972
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Metabolic Associated Fatty Liver Disease
Start date
2023-03-11
Primary completion
2025-11-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.